When a cardiologist opens a stent package in a cath lab, they are trusting more than the device itself. They are trusting every hand it passed through since it left the manufacturer’s line — the trucks it rode in, the warehouses it sat in, and the temperature it was kept at along the way. For most consumer products, a delay or a warm afternoon in transit is a minor inconvenience. For cardiology devices and the drugs that accompany them, it can mean a device that fails during implantation or a batch that has to be pulled and destroyed.
This is the problem that Good Distribution Practice (GDP) exists to solve. In Pakistan, where cardiology device demand is growing faster than the logistics infrastructure built to support it, GDP compliance is quickly becoming the line between distributors hospitals can rely on and distributors they can’t. This guide breaks down what GDP-compliant cold chain distribution actually means, why it matters more for cardiology devices than almost any other product category, and what hospitals and procurement teams should be checking before they sign with a supplier.
What Does "GDP-Compliant" Actually Mean?
Good Distribution Practice is a set of quality standards, originally laid out by the World Health Organization, that govern how pharmaceutical products and medical devices are stored, handled, and transported after they leave the factory. Most people are familiar with the manufacturing side of this equation — Good Manufacturing Practice (GMP) — because it’s the standard printed on packaging and referenced in regulatory approvals. GDP is its less visible counterpart, and arguably the more fragile one, because it covers everything that happens after manufacturing: the “last mile” between a certified factory and a hospital shelf.
A device can be manufactured to the highest GMP standard in the world and still arrive damaged, degraded, or compromised if the distributor handling it afterward doesn’t maintain the same discipline. That is the core idea behind GDP: quality doesn’t end at the factory gate, it has to be preserved all the way to the point of use.
In Pakistan, distribution of pharmaceuticals and medical devices falls under the oversight of the Drug Regulatory Authority of Pakistan (DRAP), which sets licensing and handling requirements for importers and distributors. But regulatory licensing is a floor, not a ceiling. GDP compliance, done properly, is an operational discipline — documented storage conditions, trained staff, validated transport, and traceability — not just a certificate on a wall.
Why Cold Chain Integrity Is Non-Negotiable for Cardiology Devices
Cardiology is one of the least forgiving categories in healthcare distribution, for two reasons: the products are often temperature-sensitive, and the clinical stakes of a failure are immediate and severe.
Temperature Sensitivity of Cardiology Devices and Drugs
Many products in interventional cardiology are more delicate than they look. Drug-eluting stents carry polymer coatings designed to release medication at a controlled rate — coatings that can degrade if exposed to heat during transport or storage. Injectable cardiac medications, such as antiplatelet and thrombolytic agents used in acute cardiac care, typically carry strict storage temperature ranges specified by the manufacturer. Diagnostic reagents used in cardiac catheterization labs can lose accuracy outside their specified range. None of these failures are visible on the outside of the packaging. A box that looks completely normal can contain a product that has already been compromised.
What Happens When Cold Chain Fails
A cold chain failure in cardiology distribution doesn’t just mean wasted inventory, although that is a real and costly consequence. It means a device or drug that may not perform as expected during a procedure — at the exact moment a patient’s life depends on it working correctly. Unlike a delayed shipment of, say, office supplies, a cold chain lapse in cardiology carries direct patient safety risk, potential liability for the hospital that used the product, and reputational risk for everyone in the supply chain, from manufacturer to distributor to the procuring institution. This is precisely why hospitals procuring cardiology devices need to treat their distribution partner’s cold chain discipline as a clinical decision, not just a logistics one.
Pakistan’s Cardiology Device Distribution Landscape
Cardiovascular disease remains one of the leading causes of death in Pakistan, and demand for cardiology devices — stents, catheters, diagnostic and monitoring equipment, and related pharmaceuticals — has grown accordingly across both public and private healthcare institutions. Major cardiac centers such as the Armed Forces Institute of Cardiology, the National Institute of Cardiovascular Diseases, and provincial institutes of cardiology in Punjab, Faisalabad, and Wazirabad, alongside large teaching hospitals like PIMS, Ayub Teaching Hospital, and Hayatabad Medical Complex, represent some of the highest-volume demand centers for cardiology devices in the country.
What’s less visible from the outside is how fragmented the distribution infrastructure supporting that demand often is. Cold chain logistics require consistent investment — refrigerated vehicles, validated warehouse storage, and trained handling staff — that not every distributor maintains uniformly across the country. Coverage that looks reliable in major cities like Islamabad, Lahore, or Karachi can degrade quickly once a shipment moves toward a smaller city or a more remote facility. For a hospital procurement team, this means the distributor’s actual operational reach and cold chain consistency matter as much as their catalog of available products.
This is also why device provenance matters. A cardiology device that has cleared customs and regulatory checks in Pakistan has met the country’s import standards — but what happens to it between the port and the hospital shelf is governed entirely by the distributor’s own GDP discipline, not by any single inspection at the border.
Pakistan’s Climate Makes Cold Chain Discipline Even More Critical
Cold chain logistics are hard enough in a climate-controlled environment. In Pakistan, where summer road temperatures in cities like Multan, Sukkur, and Jacobabad routinely climb past 45°C, an unrefrigerated delivery vehicle sitting in traffic for even an hour can push a temperature-sensitive shipment outside its safe range. Add to that the reality of intermittent grid power in many parts of the country, and warehouse refrigeration becomes a genuine operational challenge rather than a given — a facility without backup power or generator capacity can lose cold storage integrity during a routine outage, often without anyone noticing until it’s too late.
This is one of the most overlooked variables in cardiology device distribution. A distributor can have excellent paperwork and still fail on the ground if their vehicles aren’t properly refrigerated or their warehouses don’t have reliable backup power during load-shedding. Hospitals evaluating a distribution partner should ask specifically how cold chain integrity is maintained during power outages and peak summer months — not just what the standard operating procedure says on paper, but what actually happens when the grid goes down at 2 p.m. in June.
How GDP Compliance Protects Hospitals and Patients
For a hospital or clinic, working with a GDP-compliant distributor isn’t just about avoiding damaged stock. It directly supports several things procurement and clinical governance teams care about:
Traceability. GDP-compliant distributors maintain batch and lot-level tracking, so if a manufacturer issues a recall or a quality alert, every affected unit can be identified and located quickly — rather than discovered only after it has been used.
Documented chain of custody. Every step a product takes, from receiving to storage to final delivery, is logged. This gives hospitals a paper trail they can point to during audits, accreditation reviews, or in the rare event that a product’s performance is called into question.
Temperature-controlled storage and transport, with records. Products aren’t just kept cold — the temperature is logged and retained, so there’s verifiable proof that a device or medication stayed within its required range for its entire journey.
Reduced institutional liability. When something goes wrong with a device, one of the first questions asked is whether it was stored and transported correctly. A hospital sourcing from a GDP-compliant distributor has documentation to answer that question. One sourcing from an undocumented supply chain does not.
Audit and accreditation readiness. Hospitals working toward or maintaining accreditation standards benefit directly when their suppliers can produce clean GDP documentation on request, rather than scrambling to reconstruct a shipment’s history after the fact.
What Hospitals and Clinics Should Look For in a Distribution Partner
Not every distributor that claims to be “GDP-compliant” backs that claim with real operational practice. Procurement teams evaluating a cardiology device distributor should look past the marketing language and ask for specifics. A genuinely reliable partner should be able to demonstrate:
- Documented SOPs and staff training records — written procedures for receiving, storage, and dispatch, and proof that staff handling temperature-sensitive products have actually been trained on them.
- Validated cold chain infrastructure — refrigerated transport vehicles and warehouse storage with continuous temperature monitoring, not just a refrigerator with a thermometer taped to the door.
- Batch-level traceability systems — the ability to tell you, on request, exactly where a specific batch has been and who has handled it.
- Valid DRAP registration and licensing — current regulatory standing as an importer and distributor, not an expired or borrowed license.
- Contingency protocols — a documented plan for what happens if a delivery is delayed or a temperature excursion is detected mid-transit, rather than hoping it never happens.
- Responsive lead times — particularly important for cardiology, where a delayed device can mean a delayed or rescheduled procedure for a patient who may not have time to wait.
Asking a potential distributor to walk through these points directly — rather than accepting a general assurance that they are “certified” — is one of the simplest ways a procurement team can protect both patients and the institution’s own liability exposure.
How Greenrays Approaches GDP-Compliant Distribution
This is the standard Greenrays was built around. Every product in our cardiology device and pharmaceutical range is sourced from certified manufacturers and moved through a GDP-compliant cold chain from our warehouse to the ward — not as a slogan, but as the operational baseline for every shipment we handle. We work with major cardiac and teaching hospitals across Pakistan, and that relationship only holds up if the products we deliver arrive in exactly the condition they left the manufacturer in, every time.
If your institution is evaluating a new distribution partner for cardiology devices, or simply wants to understand how your current supply chain is being handled, our team is happy to walk through our process in detail. You can see the institutions we currently partner with or get in touch to discuss your hospital’s specific requirements.
Frequently Asked Questions
What is the difference between GMP and GDP?
GMP (Good Manufacturing Practice) governs how a product is made. GDP (Good Distribution Practice) governs how it is stored, handled, and transported after manufacturing, all the way to the end user. A product can meet GMP standards at the factory and still be compromised later if GDP isn’t maintained throughout distribution.
How is cold chain temperature monitored during distribution?
GDP-compliant distributors use continuous temperature monitoring in both storage facilities and transport vehicles, with the readings logged and retained as documented proof that products stayed within their required range throughout the journey.
Why does GDP compliance matter more for cardiology devices than other product categories?
Cardiology devices and their accompanying medications are frequently temperature-sensitive, and they are used in acute, high-stakes procedures where a compromised product can directly affect a patient’s outcome in real time. The margin for error is smaller than in most other medical device categories.
How can a hospital verify a distributor’s GDP compliance?
Ask directly for documented SOPs, staff training records, temperature monitoring logs, batch traceability capability, and current DRAP registration. A distributor with genuine GDP discipline will be able to produce these without hesitation.
The Bottom Line
GDP compliance isn’t a regulatory checkbox — it’s the difference between a cardiology device that performs exactly as the manufacturer intended and one whose reliability is a guess. For hospitals and clinics across Pakistan, the distributor sitting between your procurement order and your cath lab shelf deserves the same scrutiny as any other clinical decision. Ask for the documentation, ask about the cold chain, and don’t accept “certified” as an answer on its own.